Cassava Sciences Inc (SAVA)

NASDAQ HEALTHCARE
$1.56 +0.00% RSI 28 Oversold Add Alert

Moving Averages

SMA 200
$2.38
Price below

Company Profile

Cassava Sciences, Inc., a clinical-stage biotechnology company, develops drugs for neurodegenerative diseases. The company is headquartered in Austin, Texas.

Sector
HEALTHCARE
Industry
BIOTECHNOLOGY
Market Cap
$142.03M
P/E Ratio
None
EPS
$-2.22
Beta
-1.093
Dividend Yield
0.00%
52-Week High
$4.98
52-Week Low
$1.15

Similar stocks in BIOTECHNOLOGY

BNTX
BioNTech SE
RSI 54.0
VRTX
Vertex Pharmaceuticals Inc
RSI 37.0
CRSP
CRISPR Therapeutics AG
RSI 46.0
MRNA
Moderna Inc
RSI 35.0
VKTX
Viking Therapeutics Inc
RSI 39.0
SRPT
Sarepta Therapeutics Inc
RSI 50.0

Data last updated: March 12, 2026 at 4:18 AM EDT

Track SAVA for free

Get e-mail RSI alerts when Cassava Sciences Inc enters oversold or overbought territory. Free forever.

Add Alert